Related Experiment Video
Updated: Dec 26, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
The Role of Ambulatory Heart Failure Clinics to Avoid Heart Failure Admissions
Jessica He1, Sean Balmain2,3, Jeremy Kobulnik2,3
1Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
Intensive heart failure (HF) clinic visits can predict hospital admissions or successful avoidance of admission. This highlights the need for targeted resource allocation in HF management.
Area of Science:
- Cardiology
- Health Services Research
Background:
- The relationship between heart failure (HF) clinic services and patient outcomes is complex.
- Ambulatory HF clinic activity may influence both hospital admissions and their avoidance.
Purpose of the Study:
- To investigate the association between periods of high-intensity utilization (HIU) in ambulatory HF clinics and subsequent hospital admissions or avoided admissions.
- To determine if intensive clinic activity can predict patient disposition.
Main Methods:
- A retrospective cohort study analyzed 1728 clinic visits in an ambulatory HF clinic in 2013.
- High-intensity utilization (HIU) periods were defined as ≥2 clinic visits within 30 days.
- HIU periods were classified based on association with hospital admission or avoided admission within ±30 days.
Main Results:
- 18.8% of clinic visits occurred during HIU periods, involving 13.7% of the patient population.
- 38% of HIU periods were linked to 62 hospital admissions, with 58% for HF.
- 17 HIU periods indicated avoided admissions, and 7 post-discharge HIU periods also suggested avoided admissions.
Conclusions:
- Intensive ambulatory clinic activity identifies patients with high comorbidity burdens and varying admission risks.
- These intensive periods were associated with successful management, including decongestion with oral diuretics, leading to avoided admissions.
- Identifying patients likely to require admission versus those manageable in the clinic can optimize resource allocation for heart failure care.
Background:
There is a complex relationship between heart failure (HF) clinic services and health outcomes. We hypothesized that ambulatory clinic activity may be associated with both hospital admission and also with avoidance of admission.
Methods:
A retrospective comparative cohort study was conducted examining activity in an ambulatory HF Clinic. Consecutive clinic visits in 2013 were recorded (n = 1728) and periods of high-intensity utilization (HIU) were identified (n = 128). A HIU period was defined by ≥2 consecutive clinic visits within 30 days, ending after 30 days passed without an additional clinic visit. For each HIU period identified, patient characteristics (n = 107) and all clinic visits (n = 324) were examined. HIU periods were then classified by association with hospital admission (±30 days).
Results:
In 2013, 18.8% of all clinic visits occurred during HIU periods, involving 13.7% of the clinic population. Thirty-eight percent of HIU periods were associated with 62 total hospital admissions (±30 days), of which 58% (n = 36) were for a primary diagnosis of HF. In addition,17 HIU periods met criteria for admission avoided, and 7 HIU periods occurring after hospital discharge also met criteria for admission avoided.
Conclusions:
We identified periods of intensive ambulatory clinic activity dedicated to patients with high burdens of comorbidities and both HF and non-HF-related admissions. These periods were also associated with episodes of successful decongestion with oral diuretics, resulting in avoidance of admission. Identifying HF patients who can be treated successfully or who are likely to require admission may be helpful for allocating clinic resources.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers

